National Institute of Dental & Craniofacial Research; Notice of Closed Meetings, 33185-33186 [05-11226]

Download as PDF Federal Register / Vol. 70, No. 108 / Tuesday, June 7, 2005 / Notices Licensing Contact: Susan Ano; 301/ 435–5515; anos@mail.nih.gov. This technology describes retroviruslike particles and their production from retroviral constructs in which the gene encoding all but seven amino acids of the nucleocapsid (NC) protein was deleted. This deletion functionally eliminates packaging of the genomic RNA, thus resulting in non-infectious retrovirus-like particles. These particles can be used in vaccines or immunogenic compositions. Specific examples using HIV–1 constructs are given. Furthermore, efficient formation of these particles requires inhibition of the protease enzymatic activity, either by mutation to the protease gene in the construct or by protease inhibitor thereby ensuring the production of noninfectious retrovirus-like particles. This technology is further described in Ott et al., Journal of Virology, 2003, 77(5), 5547. Dated: May 26, 2005. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer,National Institutes of Health. [FR Doc. 05–11221 Filed 6–6–05; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in secions 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate jul<14>2003 20:54 Jun 06, 2005 Jkt 205001 Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: June 16, 2005. Open: 8:30 a.m. to 1 p.m. Agenda: Discussion of program policies and issues. Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892. Closed: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892. Contact Person: Deborah P. Beebe, PhD, Director, Division of Extramural Affairs, National Heart, Lung, and Blood Institute, National Institutes of Health, Two Rockledge Center, Room 7100, 6701 Rockledge Drive, Bethesda, MD 20892. 301/435–0260. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. Information is also available on the Institute’s/Center’s home page https:// www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS.) Dated: May 31, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11218 Filed 6–6–05; 8:45 am] BILLING CODE 4410–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Neurological Sciences and Disorders C, June 14, 2005, 8 a.m. to June 15, 2005, 5 p.m. Wyndham Washington, DC 1400 M PO 00000 Frm 00131 Fmt 4703 Sfmt 4703 33185 Street, NW., Washington, DC 20005 which was published in the Federal Register on April 27, 2005, 70 FR Doc: 05–8413. The meeting will be held for one day on June 14, 2005 from 8 a.m. to 5 p.m. The meeting is closed to the public. Dated: May 27, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11222 Filed 6–6–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of persoanl privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 05–84, Review K22. Date: June 30, 2005. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Soheyla Saadi, PhD, Scientific Review Administrator, Intern, Scientific Review Branch, 45 Center Dr. Rm 4AN32A, National Inst of Dental & Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, (301) 594–4805, saadisoh@nidcr.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 05–79, Review R13s. Date: July 6, 2005. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Mary Kelly, Scientific Review Specialist, National Institute of E:\FR\FM\07JNN1.SGM 07JNN1 33186 Federal Register / Vol. 70, No. 108 / Tuesday, June 7, 2005 / Notices Dental & Craniofacial Res., 45 Center Drive, Natcher Bldg., RM 4AN38J, Bethesda, MD 20892–6402, (301) 594–4809,, mary_kelly@nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel, 05–74, Review R03. Date: July 8, 2005. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Soheyla Saadi, PhD, Scientific Review Administrator, Intern, Scientific Review Branch, 45 Center Dr. Rm 4AN32A, National Inst of Dental & Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, (301) 594–4805, saadisoh@nidcr.nih.gov. Time: 8 a.m. to 11 a.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 50, 50 Center Drive, Bethesda, MD 20892. Contact Person: Thomas J. Kindt, PhD, Director, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Building 10, Room 4A31, Bethesda, MD 20892, (301) 496–3006, tk9c@nih.gov. This meeting is being published less than 15 days before the meeting date because of a clerical error. In the interest of security, NIH has instituted stringent procedures for entrance into the building by nongovernment employees. Persons without a government I.D. will need to show a photo I.D. and sign-in at the security desk upon entering the building. (Catalogue of Federal Domestic Assistance Program Nos. 93–121, Oral Diseases and Disorders Research, National Institutes of Health, HHS.) Dated: May 27, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11226 Filed 6–6–05; 8:45 am] (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research, 93.856, Microbiology and Infectious Diseases Research, National Institutes of Healath, HHS). Dated: May 27, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11227 Filed 6–6–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2) notice is hereby given of a meeting of the Board of Scientific Counselors, NIAID. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAID. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Allergy and Infectious Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIAID, Division of Intramural Reserach, Board of Scientific Counselors. Date: June 6–8, 2005. VerDate jul<14>2003 20:54 Jun 06, 2005 Jkt 205001 Room 3123, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Alec Ritchie, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NID/DHHS, 6700 B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301–435–1614, aritchie@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Lymphocyte Survival and Death. Date: June 29, 2005. Time: 1 p.m. to 4 p.m.. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Paul A. Amstad, PhD., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 402–7098, pamstad@niaid.nih.gov. Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 27, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–11228 Filed 6–6–05; 8:45 am] National Institutes of Health BILLING CODE 4140–01–M National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Disease Special Emphasis Panel Review of an Unsolicited Protozoa P01 application. Date: June 23, 2005. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, PO 00000 Frm 00132 Fmt 4703 Sfmt 4703 National Institutes of Health National Library of Medicine; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the first meeting of the NIH Public Access Working Group under the National Library of Medicine’s (NLM) Board of Regents. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The mission of the NIH Public Access Working Group is to advise the NLM Board of Regents on implementation of the new NIH Public Access Policy. This policy responds to strong Congressional interest in improving the public’s access to the published results of NIH-funded research. Under the policy, NIH- E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 70, Number 108 (Tuesday, June 7, 2005)]
[Notices]
[Pages 33185-33186]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-11226]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental & Craniofacial Research; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of persoanl privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel, 05-84, Review K22.
    Date: June 30, 2005.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Soheyla Saadi, PhD, Scientific Review 
Administrator, Intern, Scientific Review Branch, 45 Center Dr. Rm 
4AN32A, National Inst of Dental & Craniofacial Research, National 
Institutes of Health, Bethesda, MD 20892, (301) 594-4805, 
saadisoh@nidcr.nih.gov.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel, 05-79, Review R13s.
    Date: July 6, 2005.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mary Kelly, Scientific Review Specialist, 
National Institute of

[[Page 33186]]

Dental & Craniofacial Res., 45 Center Drive, Natcher Bldg., RM 
4AN38J, Bethesda, MD 20892-6402, (301) 594-4809,, mary_
kelly@nih.gov.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel, 05-74, Review R03.
    Date: July 8, 2005.
    Time: 1 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Soheyla Saadi, PhD, Scientific Review 
Administrator, Intern, Scientific Review Branch, 45 Center Dr. Rm 
4AN32A, National Inst of Dental & Craniofacial Research, National 
Institutes of Health, Bethesda, MD 20892, (301) 594-4805, 
saadisoh@nidcr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93-121, Oral 
Diseases and Disorders Research, National Institutes of Health, 
HHS.)

    Dated: May 27, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-11226 Filed 6-6-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.